• 1
    Beral V Evans S, Shaw H, Milton G. Cutaneous factors related to the risk of malignant melanoma. Br J Dermatol 1983; 109:165172.
  • 2
    Dubin N Moseson M, Pasternack BS. Epidemiology of malignant melanoma: Pigmentary traits, ultraviolet radiation, and the identification of high-risk populations. Recent Results Cancer Res 1986; 102:5675.
  • 3
    Holman CDJ Armstrong BK. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Nail Cancer Inst 1984; 72:257266.
  • 4
    Green A MacLennan R, Siskind V. Common acquired naevi and the risks of malignant melanoma. Int J Cancer 1985; 35:297300.
  • 5
    Elwood JM Williamson C, Stapleton PJ. Malignant melanoma in relation to moles, pigmentation, and exposure to fluorescent light and other lighting sources. Br J Cancer 1986; 53:6574.
  • 6
    Swerdlow AJ English J, MacKie RM, O'Doherty CJ, Hunter JAA, Clark J. Benign naevi associated with high risk of melanoma. Lancet 1984; 2:168.
  • 7
    Swerdlow AJ English J, Mackie RM, et al. Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J 1986; 292:15551559.
  • 8
    Holly AE Kelly JW, Shpall SN, Shu-Hui Chiu. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987; 17:459468.
  • 9
    Grob JJ Andrac L, Romano MH, et al. Dysplastic nevus in non familial melanoma: A clinico-pathological study of 101 cases. Br J Dermatol 1988; 118:745752.
  • 10
    Ackerman AB. Pathology of Malignant Melanoma. New York: Masson, 1981.
  • 11
    Schlesselman JJ. Case control study design conduct and analysis. New York: Oxford University Press, 1982; 227280.
  • 12
    Kelly JW Crutcher WA, Sagebiel RW. Clinical diagnosis of dysplastic melanocytic nevi. J Am Acad Dermatol 1986; 14:10441052.
  • 13
    Kuehn-Petzoldt C. Dysplastic nevus syndrome is not always correlated with histologic dysplasia. J Invest Dermatol 1986; 3:323.
  • 14
    Piepkorn M Meyer LJ, Goldgaz D, et al. The dysplastic nevus: A prevalent lesion that correlates poorly with clinical phenotype. J Am Acad Dermatol 1989; 3:407415.
  • 15
    Elder DE Clark WM. Developmental biology of malignant melanoma. In: ElderE, ed. Pathobiology of Malignant Melanoma: Pigment Cell, vol. 8. Basel: Karger, 1987; 128.
  • 16
    Rhodes AR Sober AJ, Mihm MC, et al. Possible risk factors for primary cutaneous melanoma (Abstr). Clin Res 1980; 28:252.
  • 17
    Elder DE Greene MH Bondi EE. Acquired melanocytic nevi and melanoma: The dysplastic nevus syndrome. In: AckermanAB, ed. Pathology of Malignant Melanoma. New York: Masson, 1981; 185216.
  • 18
    Nordlund JJ Kirwood JK, Forget BM, et al. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res 1985; 45:18551861.
  • 19
    Roush GC Nordhead JJ, Forget B, et al. Independence of dysplastic nevi from total nevi in determining risk for non familial melanoma. Prev Med 1988; 17:273279.
  • 20
    Armstrong BK English DR. The epidemiology of acquired melanocytic naevi and their relationship to malignant melanoma. In: ElwoodJM, ed. Melanoma and Nevi: Pigment Cell, vol 9. Basel: Karger, 1988; 2747.